Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
21.75
+0.30 (1.40%)
Apr 29, 2025, 4:00 PM EDT - Market closed
Dianthus Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$54.33
Upside
+149.79%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $36 | Buy | Reiterates | $36 | +65.52% | Mar 12, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $84 | Strong Buy | Reiterates | $84 | +286.21% | Mar 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +83.91% | Mar 12, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +83.91% | Nov 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $48 → $52 | Buy | Maintains | $48 → $52 | +139.08% | Nov 11, 2024 |
| Raymond James | Raymond James | Buy Maintains $51 → $56 | Buy | Maintains | $51 → $56 | +157.47% | Nov 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $48 | Buy | Initiates | $48 | +120.69% | Oct 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +83.91% | Sep 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +83.91% | Aug 12, 2024 |
| Wedbush | Wedbush | Buy Maintains $38 → $36 | Buy | Maintains | $38 → $36 | +65.52% | Aug 9, 2024 |
| Baird | Baird | Buy Initiates $58 | Buy | Initiates | $58 | +166.67% | Jul 26, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +83.91% | May 16, 2024 |
| Wedbush | Wedbush | Buy Maintains $33 → $38 | Buy | Maintains | $33 → $38 | +74.71% | May 10, 2024 |
| Raymond James | Raymond James | Buy Maintains $34 → $51 | Buy | Maintains | $34 → $51 | +134.48% | Apr 18, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.